Skip to main content
Top
Published in: Sleep and Breathing 4/2016

01-12-2016 | Neurology • Original Article

Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson’s disease

Authors: Zi-jiao Yang, Jing Wei, Cheng-jie Mao, Jin-ru Zhang, Jing Chen, Xiao-yan Ji, Jun-yi Liu, Yun Shen, Kang-ping Xiong, Jun-ying Huang, Ya-ping Yang, Chun-feng Liu

Published in: Sleep and Breathing | Issue 4/2016

Login to get access

Abstract

Purpose

Retinal nerve fiber layer (RNFL) thinning occurs in Parkinson’s disease (PD) and other neurodegenerative diseases. Idiopathic RBD (iRBD) is a well-established prodromal hallmark of synucleinopathies and occurs secondary to many neurodegenerative diseases, including PD. The aim of this study is to determine whether or not retinal structures are altered with the onset of rapid eye movement (REM) sleep behavior disorders (RBD).

Methods

In all, a total of 63 patients with PD, 14 patients with idiopathic RBD, and 26 sex- and age-matched healthy controls were enrolled and underwent optical coherence tomography measurements (HD-OCT (Zeiss) ) for the average and every quadrant of RNFL thickness. The REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) was used to classify PD patients with clinically probable RBD (PD + pRBD) or without probable RBD (PD − pRBD). Patients with iRBD were identified by polysomnography.

Results

For patients with RBD (idiopathic or secondary to PD), we found a significant decrease in RNFL thickness compared with groups without RBD (PD − pRBD and healthy controls) (all p < 0.05). Average RNFL thickness in patients with iRBD is significantly thinner than in healthy controls (p < 0.05). In PD, the average RNFL thickness was dramatically thinner in the PD + pRBD group than the PD − pRBD group (p < 0.005). Compared with healthy controls, RNFL thickness was slightly thinner in the drug-naive PD group but not the PD group with drug treatment. Multiple linear regression analysis showed that RBDSQ score was negatively associated with average and inferior RNFL variation in PD (all p < 0.005).

Conclusions

The findings show that RNFL was slightly but significantly thinner in idiopathic RBD. In PD, RNFL thickness may vary depending on the presence of RBD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130:2770–2788CrossRefPubMed Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130:2770–2788CrossRefPubMed
2.
go back to reference Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16:622–630CrossRefPubMed Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16:622–630CrossRefPubMed
3.
go back to reference Chiu HF, Wing YK, Lam LC, Li SW, Lum CM, Leung T, et al. (2000) Sleep-related injury in the elderly—an epidemiological study in Hong Kong. Sleep 23:513–517CrossRefPubMed Chiu HF, Wing YK, Lam LC, Li SW, Lum CM, Leung T, et al. (2000) Sleep-related injury in the elderly—an epidemiological study in Hong Kong. Sleep 23:513–517CrossRefPubMed
4.
go back to reference Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder dementia in 81 % of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748CrossRefPubMed Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder dementia in 81 % of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748CrossRefPubMed
5.
go back to reference Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840CrossRefPubMed Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840CrossRefPubMed
6.
go back to reference Neikrug AB, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, et al. (2014) Parkinson’s disease and REM sleep behavior disorder result in increased non-motor symptoms. Sleep Med 15:959–966CrossRefPubMedPubMedCentral Neikrug AB, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, et al. (2014) Parkinson’s disease and REM sleep behavior disorder result in increased non-motor symptoms. Sleep Med 15:959–966CrossRefPubMedPubMedCentral
7.
go back to reference Hu Y, Yu SY, Zuo LJ, Cao CJ, Wang F, Chen ZJ, et al. (2015) Parkinson disease with REM sleep behavior disorder: features, α-synuclein, and inflammation. Neurology 84:888–894CrossRefPubMed Hu Y, Yu SY, Zuo LJ, Cao CJ, Wang F, Chen ZJ, et al. (2015) Parkinson disease with REM sleep behavior disorder: features, α-synuclein, and inflammation. Neurology 84:888–894CrossRefPubMed
8.
go back to reference Joutsa J, Gardberg M, Röyttä M, Kaasinen V (2014) Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord 20:840–844CrossRefPubMed Joutsa J, Gardberg M, Röyttä M, Kaasinen V (2014) Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord 20:840–844CrossRefPubMed
9.
go back to reference Theelen T (2014) Photoreceptor layer thinning is not specific for Parkinson’s disease. Mov Disord 29:1331–1332CrossRefPubMed Theelen T (2014) Photoreceptor layer thinning is not specific for Parkinson’s disease. Mov Disord 29:1331–1332CrossRefPubMed
10.
go back to reference Jiménez B, Ascaso FJ, Cristóbal JA, López DVJ (2014) Development of a prediction formula of Parkinson disease severity by optical coherence tomography. Mov Disord 29:68–74CrossRefPubMed Jiménez B, Ascaso FJ, Cristóbal JA, López DVJ (2014) Development of a prediction formula of Parkinson disease severity by optical coherence tomography. Mov Disord 29:68–74CrossRefPubMed
11.
go back to reference Lee JY, Ahn J, Kim TW, Jeon BS (2014) Optical coherence tomography in Parkinson’s disease: is the retina a biomarker. J Parkinsons Dis 4:197–204PubMed Lee JY, Ahn J, Kim TW, Jeon BS (2014) Optical coherence tomography in Parkinson’s disease: is the retina a biomarker. J Parkinsons Dis 4:197–204PubMed
12.
go back to reference Yu JG, Feng YF, Xiang Y, Huang JH, Savini G, Parisi V, et al. (2014) Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One 9:e85718CrossRefPubMedPubMedCentral Yu JG, Feng YF, Xiang Y, Huang JH, Savini G, Parisi V, et al. (2014) Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One 9:e85718CrossRefPubMedPubMedCentral
13.
go back to reference Kramer SG, Potts AM, Mangnall Y (1971) Dopamine: a retinal neurotransmitter. II. Autoradiographic localization of H3-dopamine in the retina. Investig Ophthalmol 10:617–624 Kramer SG, Potts AM, Mangnall Y (1971) Dopamine: a retinal neurotransmitter. II. Autoradiographic localization of H3-dopamine in the retina. Investig Ophthalmol 10:617–624
14.
go back to reference Harnois C, Di PT (1990) Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest Ophthalmol Vis Sci 31:2473–2475PubMed Harnois C, Di PT (1990) Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest Ophthalmol Vis Sci 31:2473–2475PubMed
15.
go back to reference Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, et al. (2014) Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson’s disease subjects. Neurosci Lett 571:34–38CrossRefPubMedPubMedCentral Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, et al. (2014) Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson’s disease subjects. Neurosci Lett 571:34–38CrossRefPubMedPubMedCentral
16.
go back to reference Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793–2797CrossRefPubMed Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793–2797CrossRefPubMed
17.
go back to reference Moreno-Ramos T, Benito-León J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. J Alzheimers Dis 34:659–664PubMed Moreno-Ramos T, Benito-León J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. J Alzheimers Dis 34:659–664PubMed
18.
go back to reference Satue M, Garcia-Martin E, Fuertes I, Otin S, Alarcia R, Herrero R, et al. (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients. Eye (Lond) 27:507–514CrossRef Satue M, Garcia-Martin E, Fuertes I, Otin S, Alarcia R, Herrero R, et al. (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients. Eye (Lond) 27:507–514CrossRef
19.
go back to reference Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. Sleep Med 12:711–713CrossRefPubMed Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. Sleep Med 12:711–713CrossRefPubMed
20.
go back to reference Poryazova R, Oberholzer M, Baumann CR, Bassetti CL (2013) REM sleep behavior disorder in Parkinson’s disease: a questionnaire-based survey. J Clin Sleep Med 9:55–59APubMedPubMedCentral Poryazova R, Oberholzer M, Baumann CR, Bassetti CL (2013) REM sleep behavior disorder in Parkinson’s disease: a questionnaire-based survey. J Clin Sleep Med 9:55–59APubMedPubMedCentral
21.
go back to reference Montplaisir J, Gagnon JF, Fantini ML, Postuma RB, Dauvilliers Y, Desautels A, et al. (2010) Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 25:2044–2051CrossRefPubMed Montplaisir J, Gagnon JF, Fantini ML, Postuma RB, Dauvilliers Y, Desautels A, et al. (2010) Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 25:2044–2051CrossRefPubMed
22.
go back to reference American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events—rules, terminology and technical specifications. American Academy of Sleep Medicine, Westchester, IL American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events—rules, terminology and technical specifications. American Academy of Sleep Medicine, Westchester, IL
23.
24.
go back to reference Postuma RB, Gagnon JF, Montplaisir J (2013) Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 14:763–767CrossRefPubMed Postuma RB, Gagnon JF, Montplaisir J (2013) Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 14:763–767CrossRefPubMed
25.
go back to reference Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, et al. (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77:830–839CrossRefPubMed Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, et al. (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77:830–839CrossRefPubMed
26.
go back to reference Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis Res 37:3509–3529CrossRefPubMed Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis Res 37:3509–3529CrossRefPubMed
27.
go back to reference Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, et al. (2013) Remodeling of the fovea in Parkinson disease. J Neural Transm 120:745–753CrossRefPubMed Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, et al. (2013) Remodeling of the fovea in Parkinson disease. J Neural Transm 120:745–753CrossRefPubMed
28.
go back to reference Sen A, Tugcu B, Coskun C, Ekinci C, Nacaroglu SA (2014) Effects of levodopa on retina in Parkinson disease. Eur J Ophthalmol 24:114–119CrossRefPubMed Sen A, Tugcu B, Coskun C, Ekinci C, Nacaroglu SA (2014) Effects of levodopa on retina in Parkinson disease. Eur J Ophthalmol 24:114–119CrossRefPubMed
29.
30.
go back to reference Schmoll C, Lascaratos G, Dhillon B, Skene D, Riha RL (2011) The role of retinal regulation of sleep in health and disease. Sleep Med Rev 15:107–113CrossRefPubMed Schmoll C, Lascaratos G, Dhillon B, Skene D, Riha RL (2011) The role of retinal regulation of sleep in health and disease. Sleep Med Rev 15:107–113CrossRefPubMed
32.
go back to reference Braak H, Del TK, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–5PubMed Braak H, Del TK, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–5PubMed
Metadata
Title
Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson’s disease
Authors
Zi-jiao Yang
Jing Wei
Cheng-jie Mao
Jin-ru Zhang
Jing Chen
Xiao-yan Ji
Jun-yi Liu
Yun Shen
Kang-ping Xiong
Jun-ying Huang
Ya-ping Yang
Chun-feng Liu
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 4/2016
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-016-1366-4

Other articles of this Issue 4/2016

Sleep and Breathing 4/2016 Go to the issue

Sleep Breathing Physiology and Disorders • Original Article

Telemonitoring of CPAP therapy may save nursing time

Sleep Breathing Physiology and Disorders • Letter to the Editors (Invited)

Probing the prevalence of central sleep apnea in patients with chronic kidney disease

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.